14 agosto 2014
An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, investigators have discovered. The researchers demonstrated in a mouse model of the disorder that the enzyme asfotase-alpha improves bone growth, mineralization and strength.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/9JxreYGegzo/140814124736.htm
